1 – 50 of 96
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Budget impact analysis of introducing digital breast tomosynthesis in breast cancer screening in Italy
(
- Contribution to journal › Article
- 2023
-
Mark
A multiparametric approach to predict triple-negative breast cancer including parameters derived from ultrafast dynamic contrast-enhanced MRI
(
- Contribution to journal › Article
-
Mark
Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry
(
- Contribution to journal › Article
-
Mark
Impact of breast density on diagnostic accuracy in digital breast tomosynthesis versus digital mammography : results from a European screening trial
(
- Contribution to journal › Article
-
Mark
Biomarkers Predictive of Distant Disease-free Survival Derived from Diffusion-weighted Imaging of Breast Cancer
(
- Contribution to journal › Article
-
Mark
Obesity-associated changes in molecular biology of primary breast cancer
(
- Contribution to journal › Article
- 2022
-
Mark
Breast cancer risks associated with missense variants in breast cancer susceptibility genes
(
- Contribution to journal › Article
-
Mark
Polygenic risk modeling for prediction of epithelial ovarian cancer risk
(
- Contribution to journal › Article
-
Mark
Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women
(
- Contribution to journal › Article
-
Mark
Rare germline copy number variants (CNVs) and breast cancer risk
(
- Contribution to journal › Article
-
Mark
Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers
(
- Contribution to journal › Article
-
Mark
Analysis of mammograms using artificial intelligence to predict response to neoadjuvant chemotherapy in breast cancer patients : proof of concept
(
- Contribution to journal › Article
- 2021
-
Mark
“Association of mammographic features with molecular breast tumor profiles”
(
- Contribution to journal › Article
-
Mark
Selenium and Breast Cancer. Is It Protective? Epidemiologic Evidence Regarding Risk and Prognosis
2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant
(
- Contribution to journal › Article
- 2020
-
Mark
Carboplatin dose capping affects pCR rate in HER2-positive breast cancer patients treated with neoadjuvant Docetaxel, Carboplatin, Trastuzumab, Pertuzumab (TCHP)
(
- Contribution to journal › Article
- 2019
-
Mark
Comparison between software volumetric breast density estimates in breast tomosynthesis and digital mammography images in a large public screening cohort
(
- Contribution to journal › Article
-
Mark
Hepatic arterial therapy with oxaliplatin and systemic capecitabine for patients with liver metastases from breast cancer
(
- Contribution to journal › Article
-
Mark
Circulating lipids, mammographic density, and risk of breast cancer in the Nurses’ Health Study and Nurses’ Health Study II
(
- Contribution to journal › Article
- 2017
-
Mark
Effectiveness of digital breast tomosynthesis (3D-mammography) in population breast cancer screening : A protocol for a collaborative individual participant data (IPD) meta-analysis
(
- Contribution to journal › Article
- 2016
-
Mark
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
(
- Contribution to journal › Article
-
Mark
Cartilage oligomeric matrix protein contributes to the development and metastasis of breast cancer
(
- Contribution to journal › Article
-
Mark
4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer
(
- Contribution to journal › Article
-
Mark
Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancer
(
- Contribution to journal › Article
-
Mark
Targeted MS Assay Predicting Tamoxifen Resistance in Estrogen-Receptor-Positive Breast Cancer Tissues and Sera
(
- Contribution to journal › Article
-
Mark
The advantage of laser-capture microdissection over whole tissue analysis in proteomic profiling studies
(
- Contribution to journal › Article
- 2015
-
Mark
STRIPAK components determine mode of cancer cell migration and metastasis
(
- Contribution to journal › Article
-
Mark
Exome sequencing of contralateral breast cancer identifies metastatic disease
(
- Contribution to journal › Article
-
Mark
Dermcidin exerts its oncogenic effects in breast cancer via modulation of ERBB signaling
(
- Contribution to journal › Article
- 2014
-
Mark
Differential expression of miR-139, miR-486 and miR-21 in breast cancer patients sub-classified according to lymph node status
(
- Contribution to journal › Article
-
Mark
DNA-PK inhibition by NU7441 sensitizes breast cancer cells to ionizing radiation and doxorubicin
(
- Contribution to journal › Article
- 2013
-
Mark
A novel model of dormancy for bone metastatic breast cancer cells
(
- Contribution to journal › Article
-
Mark
miR-23b regulates cytoskeletal remodeling, motility and metastasis by directly targeting multiple transcripts
(
- Contribution to journal › Article
-
Mark
mTORC1 inhibition is required for sensitivity to PI3K p110α inhibitors in PIK3CA-mutant breast cancer
(
- Contribution to journal › Article
-
Mark
WNT-5A triggers Cdc42 activation leading to an ERK1/2 dependent decrease in MMP9 activity and invasive migration of breast cancer cells
(
- Contribution to journal › Article
-
Mark
Change of mammographic density predicts the risk of contralateral breast cancer--a case-control study
(
- Contribution to journal › Article
-
Mark
Quantitative proteomic analysis of microdissected breast cancer tissues : comparison of label-free and SILAC-based quantification with shotgun, directed, and targeted MS approaches
(
- Contribution to journal › Article
- 2012
-
Mark
Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers
(
- Contribution to journal › Article
-
Mark
Prognostic implications of estrogen receptor pattern of both tumors in contralateral breast cancer
(
- Contribution to journal › Article
-
Mark
Estrogen receptor status in relation to risk of contralateral breast cancer-a population-based cohort study
(
- Contribution to journal › Article
-
Mark
Global microRNA expression profiling of high-risk ER+ breast cancers from patients receiving adjuvant tamoxifen mono-therapy : a DBCG study
(
- Contribution to journal › Article
-
Mark
The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer
(
- Contribution to journal › Article
- 2011
-
Mark
Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer
(
- Contribution to journal › Article
-
Mark
Common Genetic Variation at BARD1 Is Not Associated with Breast Cancer Risk in BRCA1 or BRCA2 Mutation Carriers
(
- Contribution to journal › Article
-
Mark
Exploring the link between MORF4L1 and risk of breast cancer
(
- Contribution to journal › Article
-
Mark
Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2
(
- Contribution to journal › Article
-
Mark
Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers
(
- Contribution to journal › Article
-
Mark
The Contribution of Risk Factors to the Higher Incidence of Invasive and In Situ Breast Cancers in Women With Higher Levels of Education in the European Prospective Investigation Into Cancer and Nutrition
(
- Contribution to journal › Article
-
Mark
The role of RANK-ligand inhibition in cancer : the story of denosumab
(
- Contribution to journal › Scientific review
- 2010
-
Mark
A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population
(
- Contribution to journal › Article